CareDx Stock Price, News & Analysis (NASDAQ:CDNA)

$7.18 0.58 (8.79 %)
(As of 12/11/2017 02:43 AM ET)
Previous Close$6.60
Today's Range$6.63 - $7.21
52-Week Range$0.76 - $7.98
Volume222,200 shs
Average Volume351,116 shs
Market Capitalization$205.38 million
P/E RatioN/A
Dividend YieldN/A
Beta1.05

About CareDx (NASDAQ:CDNA)

CareDx logoCareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function having a low probability of moderate/severe acute cellular rejection. Its products under development for transplant monitoring include AlloSure, a development-stage transplant surveillance solution, which applies next generation sequencing to detect and quantitate genetic differences between donor-derived cell-free deoxyribonucleic acid (dd-cfDNA) in the blood stream emanating from the donor heart. It offers the AlloMap Score Variability service, which provides complementary information to help personalize long-term care of heart transplant recipients.

Receive CDNA News and Ratings via Email

Sign-up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Diagnostics & Testing
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CDNA
CUSIPN/A
Phone415-287-2300

Debt

Debt-to-Equity Ratio-124.53%
Current Ratio0.55%
Quick Ratio0.35%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$40.63 million
Price / Sales5.05
Cash Flow$0.19 per share
Price / Cash37.19
Book Value$0.93 per share
Price / Book7.72

Profitability

Trailing EPS($1.81)
Net Income$-39,460,000.00
Net Margins-84.14%
Return on Equity-157.00%
Return on Assets-23.52%

Miscellaneous

Employees161
Outstanding Shares28,600,000

CareDx (NASDAQ:CDNA) Frequently Asked Questions

What is CareDx's stock symbol?

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

How were CareDx's earnings last quarter?

CareDx, Inc. (NASDAQ:CDNA) posted its earnings results on Thursday, November, 9th. The company reported ($0.15) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.17) by $0.02. The business had revenue of $12.19 million for the quarter, compared to analyst estimates of $12.05 million. CareDx had a negative net margin of 84.14% and a negative return on equity of 157.00%. The business's revenue for the quarter was down 2.3% compared to the same quarter last year. View CareDx's Earnings History.

Where is CareDx's stock going? Where will CareDx's stock price be in 2017?

4 brokers have issued 1 year price objectives for CareDx's stock. Their forecasts range from $6.50 to $12.00. On average, they anticipate CareDx's stock price to reach $8.88 in the next twelve months. View Analyst Ratings for CareDx.

Who are some of CareDx's key competitors?

Who are CareDx's key executives?

CareDx's management team includes the folowing people:

  • Michael D. Goldberg, Independent Chairman of the Board (Age 59)
  • Peter Maag Ph.D., President, Chief Executive Officer, Director (Age 49)
  • Michael Bell, Chief Financial Officer
  • Mitchell J. Nelles Ph.D., Chief Operating Officer (Age 62)
  • John J. Sninsky Ph.D., Chief Scientific Officer (Age 65)
  • Josh DeFonzo, Chief Commercial Officer (Age 34)
  • Matthew J. Meyer, Chief Business Officer (Age 46)
  • James P. Yee M.D., Ph.D., Chief Medical Officer
  • George W. Bickerstaff III, Independent Director (Age 61)
  • Fred E. Cohen Ph.D. M.D., Independent Director (Age 60)

Who owns CareDx stock?

CareDx's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Gagnon Securities LLC (7.58%), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (5.30%), Royce & Associates LP (2.77%), Private Wealth Partners LLC (0.91%), Thompson Davis & CO. Inc. (0.90%) and Perkins Capital Management Inc. (0.61%). Company insiders that own CareDx stock include James P Yee, Michael Brian Bell, Mitchell J Nelles, Neil Gagnon and Peter Maag. View Institutional Ownership Trends for CareDx.

Who bought CareDx stock? Who is buying CareDx stock?

CareDx's stock was acquired by a variety of institutional investors in the last quarter, including Private Wealth Partners LLC, Thompson Davis & CO. Inc., Perkins Capital Management Inc., Gagnon Securities LLC, Royce & Associates LP, Cambridge Investment Research Advisors Inc. and Trellus Management Company LLC. Company insiders that have bought CareDx stock in the last two years include Michael Brian Bell, Neil Gagnon and Peter Maag. View Insider Buying and Selling for CareDx.

How do I buy CareDx stock?

Shares of CareDx can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CareDx's stock price today?

One share of CareDx stock can currently be purchased for approximately $7.18.

How big of a company is CareDx?

CareDx has a market capitalization of $205.38 million and generates $40.63 million in revenue each year. The company earns $-39,460,000.00 in net income (profit) each year or ($1.81) on an earnings per share basis. CareDx employs 161 workers across the globe.

How can I contact CareDx?

CareDx's mailing address is 3260 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The company can be reached via phone at 415-287-2300 or via email at [email protected]


MarketBeat Community Rating for CareDx (CDNA)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  119 (Vote Outperform)
Underperform Votes:  106 (Vote Underperform)
Total Votes:  225
MarketBeat's community ratings are surveys of what our community members think about CareDx and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CareDx (NASDAQ:CDNA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.50$8.88$8.33$9.25
Price Target Upside: 41.79% upside57.92% upside69.03% upside87.63% upside

CareDx (NASDAQ:CDNA) Consensus Price Target History

Price Target History for CareDx (NASDAQ:CDNA)

CareDx (NASDAQ:CDNA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/27/2017HC WainwrightInitiated CoverageBuy -> Buy$12.00HighView Rating Details
10/9/2017Craig HallumReiterated RatingBuy$4.00 -> $10.00N/AView Rating Details
9/27/2017Raymond James FinancialUpgradeMarket Perform -> Buy$6.50HighView Rating Details
9/26/2017Piper Jaffray CompaniesReiterated RatingOverweight$3.00 -> $7.00HighView Rating Details
6/14/2016Leerink SwannReiterated RatingBuyN/AView Rating Details
6/14/2016MizuhoBoost Price TargetBuy$8.00 -> $12.00N/AView Rating Details
2/9/2016Janney Montgomery ScottInitiated CoverageBuy -> Buy$12.00N/AView Rating Details
(Data available from 12/11/2015 forward)

Earnings

CareDx (NASDAQ:CDNA) Earnings History and Estimates Chart

Earnings by Quarter for CareDx (NASDAQ:CDNA)

CareDx (NASDAQ CDNA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017Q3 2017($0.17)($0.15)$12.05 million$12.19 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.19)($0.19)$11.87 million$12.05 millionViewN/AView Earnings Details
11/9/2016Q3 2016($0.25)($0.17)$11.50 million$12.48 millionViewListenView Earnings Details
8/10/2016Q216($0.28)($0.29)$10.42 million$10.70 millionViewListenView Earnings Details
5/6/2016Q1($0.31)($0.37)$6.97 million$6.60 millionViewN/AView Earnings Details
3/24/2016Q415($0.34)($0.40)$7.44 million$6.60 millionViewListenView Earnings Details
11/11/2015Q315($0.25)($0.29)$7.34 million$7.15 millionViewListenView Earnings Details
8/10/2015Q215($0.18)($0.27)$7.28 million$7.13 millionViewListenView Earnings Details
5/12/2015Q115($0.17)($0.19)$6.82 million$7.22 millionViewListenView Earnings Details
11/10/2014Q314($0.13)$0.01$6.60 million$6.65 millionViewN/AView Earnings Details
8/27/2014Q2 14($0.13)($0.09)$6.18 million$6.78 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

CareDx (NASDAQ:CDNA) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.17)($0.17)($0.17)
Q3 20181($0.09)($0.09)($0.09)
Q4 20181($0.08)($0.08)($0.08)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for CareDx (NASDAQ:CDNA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

CareDx (NASDAQ CDNA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.40%
Institutional Ownership Percentage: 23.15%
Insider Trades by Quarter for CareDx (NASDAQ:CDNA)
Institutional Ownership by Quarter for CareDx (NASDAQ:CDNA)

CareDx (NASDAQ CDNA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/8/2017James P YeeInsiderSell29,197$7.00$204,379.00View SEC Filing  
11/30/2017Mitchell J NellesCOOSell10,948$7.17$78,497.16View SEC Filing  
10/5/2017Neil GagnonMajor ShareholderBuy10,642$4.00$42,568.00View SEC Filing  
9/7/2017Neil GagnonMajor ShareholderBuy6,496$3.05$19,812.80View SEC Filing  
8/28/2017Neil GagnonMajor ShareholderBuy21,448$2.77$59,410.96View SEC Filing  
8/25/2017Neil GagnonMajor ShareholderBuy35,119$2.92$102,547.48View SEC Filing  
8/15/2017Michael Brian BellCFOBuy725$1.83$1,326.75View SEC Filing  
8/15/2017Peter MaagInsiderBuy600$1.82$1,092.00View SEC Filing  
7/24/2017Neil GagnonMajor ShareholderBuy1,486$1.23$1,827.78View SEC Filing  
6/29/2017Neil GagnonMajor ShareholderBuy1,808$1.11$2,006.88View SEC Filing  
6/23/2017Neil GagnonMajor ShareholderBuy63,120$1.10$69,432.00View SEC Filing  
5/24/2017Neil GagnonMajor ShareholderBuy7,439$1.00$7,439.00View SEC Filing  
5/23/2017Neil GagnonMajor ShareholderBuy6,836$1.04$7,109.44View SEC Filing  
4/28/2017Neil GagnonMajor ShareholderBuy15,116$0.89$13,453.24View SEC Filing  
3/16/2017Neil GagnonMajor ShareholderBuy123,160$1.83$225,382.80View SEC Filing  
9/22/2016Neil GagnonMajor ShareholderBuy178,686$4.00$714,744.00View SEC Filing  
4/14/2016Neil GagnonMajor ShareholderBuy93,240$4.02$374,824.80View SEC Filing  
10/21/2015Neil Gagnonmajor shareholderBuy1,431$4.99$7,140.69View SEC Filing  
10/20/2015Neil GagnonMajor ShareholderBuy1,347$4.92$6,627.24View SEC Filing  
9/29/2015Neil Gagnonmajor shareholderBuy6,332$6.10$38,625.20View SEC Filing  
9/4/2015Neil GagnonMajor ShareholderBuy69,383$6.95$482,211.85View SEC Filing  
6/5/2015Neil GagnonMajor ShareholderBuy6,500$5.69$36,985.00View SEC Filing  
6/1/2015Peter MaagCEOBuy2,000$4.84$9,680.00View SEC Filing  
4/17/2015Neil GagnonMajor ShareholderBuy13,051$5.34$69,692.34View SEC Filing  
3/20/2015Neil GagnonMajor ShareholderBuy6,324$6.35$40,157.40View SEC Filing  
2/27/2015Neil GagnonMajor ShareholderBuy4,270$6.03$25,748.10View SEC Filing  
2/6/2015Neil GagnonMajor ShareholderBuy4,586$7.20$33,019.20View SEC Filing  
2/5/2015Neil GagnonMajor ShareholderBuy121,587$7.10$863,267.70View SEC Filing  
2/4/2015Neil GagnonMajor ShareholderBuy31,991$7.00$223,937.00View SEC Filing  
2/3/2015Neil GagnonMajor ShareholderBuy23,558$7.03$165,612.74View SEC Filing  
2/2/2015Neil GagnonMajor ShareholderBuy3,620$7.05$25,521.00View SEC Filing  
1/29/2015Neil GagnonMajor ShareholderBuy15,395$7.04$108,380.80View SEC Filing  
1/27/2015Neil GagnonMajor ShareholderBuy84,720$7.00$593,040.00View SEC Filing  
1/22/2015Neil GagnonMajor ShareholderBuy48,670$7.13$347,017.10View SEC Filing  
1/20/2015Neil GagnonMajor ShareholderBuy16,192$6.66$107,838.72View SEC Filing  
1/15/2015Neil GagnonMajor ShareholderBuy39,109$6.43$251,470.87View SEC Filing  
1/14/2015Neil GagnonMajor ShareholderBuy122,319$7.07$864,795.33View SEC Filing  
7/22/2014Ken LudlumCFOBuy7,000$10.00$70,000.00View SEC Filing  
7/22/2014Michael GoldbergDirectorBuy25,000$10.00$250,000.00View SEC Filing  
7/22/2014Perkins Caufield & Bye KleinerMajor ShareholderBuy52,770$10.00$527,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

CareDx (NASDAQ CDNA) News Headlines

Source:
DateHeadline
Insider Selling: CareDx, Inc. (CDNA) Insider Sells 29,197 Shares of StockInsider Selling: CareDx, Inc. (CDNA) Insider Sells 29,197 Shares of Stock
www.americanbankingnews.com - December 8 at 8:52 PM
The Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat PharmacyThe Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat Pharmacy
finance.yahoo.com - December 7 at 10:15 AM
Analyzing CareDx (CDNA) & Digiliti Money Group (DGLT)Analyzing CareDx (CDNA) & Digiliti Money Group (DGLT)
www.americanbankingnews.com - December 5 at 9:32 PM
CareDx (CDNA) & Digiliti Money Group (DGLT) Head to Head ReviewCareDx (CDNA) & Digiliti Money Group (DGLT) Head to Head Review
www.americanbankingnews.com - December 5 at 7:32 AM
Zacks: Brokerages Expect CareDx, Inc. (CDNA) Will Announce Quarterly Sales of $11.96 MillionZacks: Brokerages Expect CareDx, Inc. (CDNA) Will Announce Quarterly Sales of $11.96 Million
www.americanbankingnews.com - December 2 at 11:04 AM
CareDx, Inc. (CDNA) COO Mitchell J. Nelles Sells 10,948 SharesCareDx, Inc. (CDNA) COO Mitchell J. Nelles Sells 10,948 Shares
www.americanbankingnews.com - November 30 at 10:36 PM
4 Top-Ranked Growth Stocks in MedTech Under $204 Top-Ranked Growth Stocks in MedTech Under $20
finance.yahoo.com - November 30 at 4:54 PM
Zacks: Analysts Anticipate CareDx, Inc. (CDNA) Will Announce Earnings of -$0.13 Per ShareZacks: Analysts Anticipate CareDx, Inc. (CDNA) Will Announce Earnings of -$0.13 Per Share
www.americanbankingnews.com - November 30 at 3:10 AM
ETFs with exposure to CareDx, Inc. : November 27, 2017ETFs with exposure to CareDx, Inc. : November 27, 2017
finance.yahoo.com - November 27 at 6:20 PM
CareDx, Inc. (CDNA) Receives New Coverage from Analysts at HC WainwrightCareDx, Inc. (CDNA) Receives New Coverage from Analysts at HC Wainwright
www.americanbankingnews.com - November 27 at 4:44 PM
CareDx, Inc. (CDNA) Receives Consensus Recommendation of "Buy" from AnalystsCareDx, Inc. (CDNA) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - November 27 at 2:00 PM
Technical Insights on Research Services Stocks -- CareDx, INC Research, Myriad Genetics, and QIAGENTechnical Insights on Research Services Stocks -- CareDx, INC Research, Myriad Genetics, and QIAGEN
www.bizjournals.com - November 22 at 5:47 PM
CMS Releases 2018 Clinical Laboratory Fee ScheduleCMS Releases 2018 Clinical Laboratory Fee Schedule
finance.yahoo.com - November 20 at 6:11 PM
ETFs with exposure to CareDx, Inc. : November 17, 2017ETFs with exposure to CareDx, Inc. : November 17, 2017
finance.yahoo.com - November 18 at 8:35 AM
CareDx Further Simplifies its Balance SheetCareDx Further Simplifies its Balance Sheet
finance.yahoo.com - November 16 at 12:36 PM
CareDx, Inc. :CDNA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017CareDx, Inc. :CDNA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017
finance.yahoo.com - November 14 at 6:14 AM
CareDx, Inc. (CDNA) Expected to Announce Quarterly Sales of $12.01 MillionCareDx, Inc. (CDNA) Expected to Announce Quarterly Sales of $12.01 Million
www.americanbankingnews.com - November 13 at 4:16 PM
Edited Transcript of CDNA earnings conference call or presentation 9-Nov-17 9:30pm GMTEdited Transcript of CDNA earnings conference call or presentation 9-Nov-17 9:30pm GMT
finance.yahoo.com - November 10 at 10:13 AM
CareDx, Inc. (CDNA) Posts Quarterly  Earnings Results, Beats Expectations By $0.02 EPSCareDx, Inc. (CDNA) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS
www.americanbankingnews.com - November 9 at 11:23 PM
ETFs with exposure to CareDx, Inc. : November 7, 2017ETFs with exposure to CareDx, Inc. : November 7, 2017
finance.yahoo.com - November 7 at 8:01 PM
CareDx to Participate in Upcoming Investor ConferencesCareDx to Participate in Upcoming Investor Conferences
finance.yahoo.com - November 2 at 5:49 PM
CareDx Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)CareDx Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - October 31 at 6:12 PM
AlloSure data will be presented at ASNAlloSure data will be presented at ASN
feeds.benzinga.com - October 30 at 8:32 AM
CareDx, Inc. (CDNA) Short Interest UpdateCareDx, Inc. (CDNA) Short Interest Update
www.americanbankingnews.com - October 28 at 1:26 AM
CareDx to Announce Third Quarter 2017 Financial Results on November 9, 2017CareDx to Announce Third Quarter 2017 Financial Results on November 9, 2017
finance.yahoo.com - October 27 at 7:47 PM
CareDx, Inc. (CDNA) Expected to Post Quarterly Sales of $11.96 MillionCareDx, Inc. (CDNA) Expected to Post Quarterly Sales of $11.96 Million
www.americanbankingnews.com - October 24 at 5:48 AM
CareDx, Inc. (CDNA) Expected to Post Earnings of -$0.17 Per ShareCareDx, Inc. (CDNA) Expected to Post Earnings of -$0.17 Per Share
www.americanbankingnews.com - October 22 at 4:24 PM
Research Analysts Offer Predictions for CareDx, Inc.s Q1 2018 Earnings (CDNA)Research Analysts Offer Predictions for CareDx, Inc.'s Q1 2018 Earnings (CDNA)
www.americanbankingnews.com - October 13 at 11:10 AM
ETFs with exposure to CareDx, Inc. : October 10, 2017ETFs with exposure to CareDx, Inc. : October 10, 2017
finance.yahoo.com - October 11 at 6:35 PM
Craig Hallum Reaffirms "Buy" Rating for CareDx, Inc. (CDNA)Craig Hallum Reaffirms "Buy" Rating for CareDx, Inc. (CDNA)
www.americanbankingnews.com - October 9 at 10:02 AM
Neil Gagnon Buys 10,642 Shares of CareDx, Inc. (CDNA) StockNeil Gagnon Buys 10,642 Shares of CareDx, Inc. (CDNA) Stock
www.americanbankingnews.com - October 6 at 8:16 PM
How Does CareDx Inc (CDNA) Affect Your Portfolio Returns?How Does CareDx Inc (CDNA) Affect Your Portfolio Returns?
finance.yahoo.com - October 5 at 9:05 PM
CareDxs Lower Priced Stock Offering Attracts Buyers At Higher PricesCareDx's Lower Priced Stock Offering Attracts Buyers At Higher Prices
www.benzinga.com - October 5 at 4:04 PM
$11.99 Million in Sales Expected for CareDx, Inc. (CDNA) This Quarter$11.99 Million in Sales Expected for CareDx, Inc. (CDNA) This Quarter
www.americanbankingnews.com - October 5 at 1:24 AM
Short Interest in CareDx, Inc. (CDNA) Increases By 55.9%Short Interest in CareDx, Inc. (CDNA) Increases By 55.9%
www.americanbankingnews.com - September 29 at 1:56 AM
UPDATE: CareDx, Inc (CDNA) PT Raised to $7 at Piper Jaffray - StreetInsider.comUPDATE: CareDx, Inc (CDNA) PT Raised to $7 at Piper Jaffray - StreetInsider.com
www.streetinsider.com - September 27 at 10:35 PM
PAREXELs Acquisition by Pamplona Approved by ShareholdersPAREXEL's Acquisition by Pamplona Approved by Shareholders
www.zacks.com - September 27 at 5:34 PM
CareDx, Inc. (CDNA) Lifted to "Outperform" at Raymond James Financial, Inc.CareDx, Inc. (CDNA) Lifted to "Outperform" at Raymond James Financial, Inc.
www.americanbankingnews.com - September 27 at 12:22 PM
CareDx Inc (CDNA) Given "Overweight" Rating at Piper Jaffray CompaniesCareDx Inc (CDNA) Given "Overweight" Rating at Piper Jaffray Companies
www.americanbankingnews.com - September 26 at 5:38 PM
Medicare reimbursement cuts slam stocks of lab services companiesMedicare reimbursement cuts slam stocks of lab services companies
www.marketwatch.com - September 26 at 4:06 PM
MolDX sets AlloSure reimbursement at 2017 AlloMap levelMolDX sets AlloSure reimbursement at 2017 AlloMap level
finance.yahoo.com - September 26 at 8:59 AM
ETFs with exposure to CareDx, Inc. : September 25, 2017ETFs with exposure to CareDx, Inc. : September 25, 2017
finance.yahoo.com - September 25 at 7:40 PM
AlloMap’s Medicare reimbursement to increase in 2018AlloMap’s Medicare reimbursement to increase in 2018
finance.yahoo.com - September 22 at 9:06 PM
Have Investors Already Priced In CareDx Inc’s (CDNA) Growth?Have Investors Already Priced In CareDx Inc’s (CDNA) Growth?
finance.yahoo.com - September 22 at 10:16 AM
This Market Knows No FearThis Market Knows No Fear
finance.yahoo.com - September 21 at 4:52 PM
ETFs with exposure to CareDx, Inc. : September 14, 2017ETFs with exposure to CareDx, Inc. : September 14, 2017
finance.yahoo.com - September 14 at 10:51 PM
CareDx, Inc. :CDNA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017CareDx, Inc. :CDNA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
finance.yahoo.com - September 13 at 6:14 PM
CareDx, Inc. (CDNA) Major Shareholder Neil Gagnon Buys 6,496 SharesCareDx, Inc. (CDNA) Major Shareholder Neil Gagnon Buys 6,496 Shares
www.americanbankingnews.com - September 8 at 4:22 PM
Comparing CareDx (CDNA) and InVitae Corp (NVTA)Comparing CareDx (CDNA) and InVitae Corp (NVTA)
www.americanbankingnews.com - September 5 at 2:22 AM
Head-To-Head Review: CareDx (CDNA) & Lion Biotechnologies (IOVA)Head-To-Head Review: CareDx (CDNA) & Lion Biotechnologies (IOVA)
www.americanbankingnews.com - September 1 at 12:28 AM

SEC Filings

CareDx (NASDAQ:CDNA) SEC Filings

DateFilerForm TypeView
12/08/2017
6:59 PM
CareDx (Issuer)
Yee James P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/08/2017
4:13 PM
CareDx (Filer)
Form 424B3
View Filing
11/30/2017
8:23 PM
CareDx (Issuer)
Nelles Mitchell J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing

Social Media

Financials

CareDx (NASDAQ:CDNA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

CareDx (NASDAQ CDNA) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.